Suven Pharmaceuticals Limited

NSE:SUVENPHAR.NS

1076.9 (INR) • At close May 9, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q3
Omzet 3,071.52,577.22,306.92,529.3042,198.1962,310.5373,475.5013,693.5623,537.7172,784.0183,387.9913,334.2893,915.8533,009.8832,638.0132,293.8232,749.3322,373.8812,382.3241,579.1691,787.0622,729.2761,973.9142,393.4041,269.152
Kosten van de omzet 556.3520.61,4971,768.9421,051.419868.8191,335.4691,569.0011,570.0111,321.1761,394.0371,374.7421,656.9851,363.1441,155.9881,205.1261,017.2531,033.294946.362690.709708.9641,175.167662.927967.845544.009
Brutowinst 2,515.22,056.6809.9760.3621,146.7771,441.7182,140.0322,124.5611,967.7061,462.8421,993.9541,959.5472,258.8681,646.7391,482.0251,088.6971,732.0791,340.5871,435.962888.461,078.0981,554.1091,310.9871,425.559725.143
Brutowinstmarge 0.8190.7980.3510.3010.5220.6240.6160.5750.5560.5250.5890.5880.5770.5470.5620.4750.630.5650.6030.5630.6030.5690.6640.5960.571
Onderzoek- en ontwikkelingskosten 00022.75922.82244.73920.8820.0922.69820.74622.32321.44221.88536.69423.52415.06326.58538.14230.78534.07926.91552.94327.37800
Algemene en administratieve kosten 000164.609000122.774000311.28100095.779000181.75200000
Verkoop- en marketingkosten 00034.77500034.89300018.83300018.36900036.03700000
Verkoop-, algemene en administratieve kosten 00456.2199.384144.185131.598287.44157.667181.306156.824265.856330.114250.087231.943100.818114.148213.471209.29174.442217.789154.208152.579170.487162.7770
Overige kosten 1,541.72,056.60170.537143.446198.417106.651113.995130.112109.2110.331-740.383646.85150.41157.829-98.90148.4293.56857.391-125.18448.87554.45224.446235.7411.857
Bedrijfskosten 1,541.72,056.6456.2199.384622.85581.024595.787553.361623.148584.353600.178468.572503.723520.759425.864228.995438.192430.692385.782183.88337.637354.598341.38235.741285.134
Bedrijfsresultaat 973.5870.5943.9560.978667.3731,059.1111,544.2451,685.1951,474.67987.6891,393.7761,478.9911,755.1451,125.981,056.161859.7021,293.887909.8951,050.18704.58740.4611,199.511969.6071,189.818440.009
Bedrijfsresultaat ratio 0.3170.3380.4090.2220.3040.4580.4440.4560.4170.3550.4110.4440.4480.3740.40.3750.4710.3830.4410.4460.4140.4390.4910.4970.347
Totaal overige inkomsten en kosten netto 123.8124.5-113147.541-140.947-57.12895.18615.928-187.411-170.86395.815118.116639.434213.293273.0648.335-17.024-124.795-52.0591.41436.37845.431159.917-42.555-8.601
Inkomen voor belasting 1,097.3995830.9708.519654.6831,054.0831,639.4311,662.1091,460.843984.7551,489.5911,612.8212,394.5791,339.2731,329.2251,054.6971,474.999968.361,178.685893.813776.8391,244.9421,129.5241,147.263431.408
Inkomen voor belasting ratio 0.3570.3860.360.280.2980.4560.4720.450.4130.3540.440.4840.6120.4450.5040.460.5360.4080.4950.5660.4350.4560.5720.4790.34
Belastingkosten 264.4175.2223.2174.787187.148258.442433.532422.396383.637264.192414.17696.142793.889369.425278.394223.538338.746227.57263.469151.99197.735314.894210.482399.03386.895
Nettowinst 828.8819.8607.7533.73467.535795.6411,2061,239.7131,077.206720.5631,075.421916.681,600.69969.8481,050.831831.1591,136.253740.79915.216741.823579.104930.048919.042748.23344.513
Nettowinstmarge 0.270.3180.2630.2110.2130.3440.3470.3360.3040.2590.3170.2750.4090.3220.3980.3620.4130.3120.3840.470.3240.3410.4660.3130.271
WPA (Winst Per Aandeel) 3.263.232.392.11.843.134.744.874.232.834.223.66.293.814.133.264.462.913.62.912.273.653.612.941.35
Verwaterde WPA 3.233.212.392.11.843.134.744.874.232.834.223.66.293.814.133.264.462.913.62.912.273.653.612.941.35
EBITDA 1,334.11,181.3799.3903.976794.8911,178.031,776.3081,804.7781,597.061,107.9941,619.1531,738.9162,507.0561,268.1611,203.923969.8871,429.891988.4651,178.2051,005.016845.331,344.5271,049.0261,213.553497.267
EBITDA ratio 0.4340.4580.3460.3570.3620.510.5110.4890.4510.3980.4780.5220.640.4210.4560.4230.520.4160.4950.6360.4730.4930.5310.5070.392